Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC. -- Ignore unavailable to you. Want to Upgrade?

To: Epics who wrote (91)	11/20/1997 2:10:00 PM
From: Elroy	Respond to of 211

Good news? At least its interesting news.... The press release says: "At the Franciscan Medical Center located in Dayton, Ohio, Hans H. J. Zwart, MD & Associates were the first to use GSI's ENDOSAPH system in three procedures for minimally invasive harvesting of the saphenous vein for use in coronary artery bypass graft (CABG) procedures." So I call 411 and get the area code for Dayton Ohio, (it's 937), and call 1-937-555-1212, and ask for a Franciscan Medical Center in Dayton, Ohio, and, well, it doesn't exist..... Go ahead and call information yourself, and see if you can find the phone number for a Franciscan Medical Center in Dayton, Ohio. It's probably only a typo, but if a company puts out about one press release per month, you'd figure they'd get it right.

To: Epics who wrote (91)	11/21/1997 12:07:00 PM
From: Lighthouse	Read Replies (1) \| Respond to of 211

Yes, good news. This center had been using the earlier Saphenous Vein balloon from GSI, so it probably is no surprise to see them listed. Still paying more for the new product and using it three times in the inital week . . . that's definitely positive. That's probably one rep from GSI, now if all the reps had this kind of success . . . . I called the Franciscan Medical Center (Yes it does exist) and tried to get in touch with Dr. Zwart. Unfortunately he does not have voice mail, but I will try again. I also liked today's press release on the dissector/expander. This will never be as large a market as the hernia/spahenous vein field, but it still should provide some decent $'s and broadens the company's product lienup. Overall cost of plastic/reconstructive procedures looks neutral to positive for the GSI product and the patient probably likes it a lot better. Ramp is anybody's guess . . . . What's your take? Regards